Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Background: Unresectable locally advanced or metastatic triple-negative (hormone-receptor-negative and human epidermal growth factor receptor 2 [HER2]-negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)-paclitaxel may enhance the anticancer activity of atezolizumab.
atezolizumab、advanced、cancer、breast、nab-paclitaxel、triple-negative
45
R734.2;R979.1;R542.21
2023-10-24(万方平台首次上网日期,不代表论文的发表时间)
共1页
1917